Bhattacharjee Nandini, Khuda-Bukhsh Anisur Rahman
Cytogenetics and Molecular Biology Laboratory, Department of Zoology, University of Kalyani, Kalyani, India.
J Acupunct Meridian Stud. 2012 Aug;5(4):166-75. doi: 10.1016/j.jams.2012.05.004. Epub 2012 Jun 8.
The purpose of the study was to evaluate whether potentized cholesterinum (Chol) intermittently used with another homeopathic remedy, Natrum Sulphuricum (Nat Sulph) can provide additional benefits in combating hepatotoxicity generated by chronic feeding of carcinogens, p-dimethylaminoazobenzene (p-DAB), and phenobarbital (PB). Mice were categorized into subgroups: normal untreated (Gr-1); normal + alcohol "vehicle" (Alc) (Gr-2), 0.06% p-DAB +0.05% PB (Gr-3), p-DAB+PB+Alc (Gr-4), p-DAB+PB+Nat Sulph-30 (Gr-5), p-DAB+PB+Chol-200 (Gr-6), p-DAB+PB+Nat Sulph-30+Chol-200 (Gr-7), p-DAB+PB+Nat Sulph-200 (Gr-8), and DAB+PB+Nat Sulph-200+Chol-200 (Gr-9). Hepatotoxicity was assessed through biomarkers like aspartate and alanine aminotransferases (AST and ALT), acid and alkaline phosphatases (AcP and AlkP), reduced glutathione content (GSH), glucose 6-phosphate dehydrogenase (G6PD), gamma glutamyl transferase (GGT), lactate dehydrogenase (LDH), and analysis of lipid peroxidation (LPO) at 30, 60, 90, and 120 days and antioxidant biomarkers like superoxide dismutase (SOD), catalase (CAT), and glutathione reductase (GR) were assayed. Electron microscopic studies (scanning and transmission) and gelatin zymography for matrix metalloproteinases were conducted in liver. The feeding of the homeopathic drugs showed intervention in regard to the increased activities of AST, ALT, AcP, AlkP, GGT, LDH, and LPO and decreased activities of G6PD, SOD, CAT, GR, and GSH noted in the intoxicated mice, more appreciable in Groups 7 and 9. Thus, combined therapy provided additional antihepatotoxic and anticancer effects.
本研究的目的是评估与另一种顺势疗法药物硫酸钠(Nat Sulph)间歇联用的增效胆固醇(Chol)在对抗由长期喂食致癌物对二甲氨基偶氮苯(p-DAB)和苯巴比妥(PB)所产生的肝毒性方面是否能带来额外益处。将小鼠分为亚组:正常未处理组(Gr-1);正常 + 酒精“赋形剂”(Alc)组(Gr-2),0.06% p-DAB + 0.05% PB组(Gr-3),p-DAB + PB + Alc组(Gr-4),p-DAB + PB + 硫酸钠-30组(Gr-5),p-DAB + PB + 胆固醇-200组(Gr-6),p-DAB + PB + 硫酸钠-30 + 胆固醇-200组(Gr-7),p-DAB + PB + 硫酸钠-200组(Gr-8),以及DAB + PB + 硫酸钠-200 + 胆固醇-200组(Gr-9)。通过生物标志物如天冬氨酸和丙氨酸转氨酶(AST和ALT)、酸性和碱性磷酸酶(AcP和AlkP)、还原型谷胱甘肽含量(GSH)、葡萄糖6-磷酸脱氢酶(G6PD)、γ-谷氨酰转移酶(GGT)、乳酸脱氢酶(LDH)来评估肝毒性,并在第30、60、90和120天分析脂质过氧化(LPO)情况,同时检测抗氧化生物标志物如超氧化物歧化酶(SOD)、过氧化氢酶(CAT)和谷胱甘肽还原酶(GR)。对肝脏进行了电子显微镜研究(扫描和透射)以及基质金属蛋白酶的明胶酶谱分析。顺势疗法药物的喂食显示出对中毒小鼠中AST、ALT、AcP、AlkP、GGT、LDH和LPO活性增加以及G6PD, SOD, CAT, GR和GSH活性降低的干预作用,在第7组和第9组中更为明显。因此,联合疗法具有额外的抗肝毒性和抗癌作用。